Pain Management

At the American Academy of Pain Medicine’s 2017 Annual Meeting, survey results were presented that revealed the implications of naloxone use in real-world experiences with the recently approved intranasal naloxone formulation.

The meeting theme this year, Pain as a Public Health Issue, emphasizes the extent to which pain affects the US population, with more than 100 million Americans suffering from pain.

To the dismay of many health care professionals, opioid abuse has become an epidemic in the United States.

Patients with low back pain should initially seek non-drug therapy.

Prescribers and pharmacists in various clinical roles are often challenged when treating patients with comorbid chronic pain and end-stage renal disease (ESRD) or hemodialysis (HD). There is a dearth of clinical guidelines available for chronic pain management in this setting. Those selecting pharmacotherapy for patients must rely on clinical judgement, literature analysis and prudent decision making.

On February 15 2017, Governor Chris Christie of New Jersey signed legislation aimed to curb the state’s opioid addiction epidemic

Before you read this article, take a moment and see if you remember the 7 or 8 black box warnings associated with long acting opioid pain medications.

Sixty percent to 90% of patients with cancer with bone metastasis develop bone pain. In turn, bone pain can be the first sign that cancer has spread to the bone.

$101 billion was spent on diabetes in 2013, which made it the top health spending category.

The survey found 65.5% of veterans experienced pain within the past 3 months.

Purdue and Shionogi will co-launch Symproic to treat opioid-induced constipation.

Officials with Elite Pharmaceuticals have filed an abbreviated new drug application with the FDA for a generic version of Norco (hydrocodone bitartrate and acetaminophen tablets) in doses of 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg.

AcelRX has submitted a New Drug Application (NDA) to the FDA for ARX-04 (sufentanil tablets).

Falls can cause significant mortality and morbidity in the aging population.

Egalet has submitted a supplemental new drug application (sNDA) to the FDA for Oxaydo, (oxycodone HCl, USP) in favor of an abuse-deterrent label claim for the intravenous route of abuse.

Top news of the day from across the healthcare landscape.

Pain is an important concern for patients with cancer, although not every patient with cancer will experience pain.

Lexicon Pharmaceuticals and Bristol-Myers Squibb launch drug discovery alliance.

Top news of the day from across the health care landscape.

Only 13% of patients taking opioids for low back pain said the treatment was very successful.

Patients insured through Medicaid experienced high levels of pain in the post anesthesia care unit.

How can you help a patient prepare for the additional medication costs and lifestyle challenges he may be facing?

Melatonin: it's more than just a sleep aid.

New research highlights the need for earlier access to effective pain medications among advanced cancer patients.

Meperidine was synthetically derived in 1939 as an anticholinergic agent, but was discovered to possess analgesic properties shortly after.

Ointment shows promise preventing neuropathy.

Community pharmacists are frontline providers in helping patients control and manage acute and chronic pain.

Complementary health approaches for managing pain conditions may reduce opioid prescriptions.

Morphine tolerance found to be caused by an inflammatory response in the brain.